CHEBI:50663 - zanamivir

ChEBI IDCHEBI:50663
ChEBI Namezanamivir
Stars
Secondary ChEBI IDsCHEBI:10104, CHEBI:46607
Last Modified22 February 2017
SubmitterKirill Degtyarenko
DownloadsMolfile
FormulaC12H20N4O7
Net Charge0
Average Mass332.313
Monoisotopic Mass332.13320
SMILES[H][C@@]1([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]1NC(C)=O
InChIInChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
InChIKeyARAIBEBZBOPLMB-UFGQHTETSA-N
Wikipedia
Roles Classification
Biological Roles:
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor  An antiviral drug targeted at influenza viruses. Its mode of action consists of blocking the function of the viral neuraminidase protein (EC 3.2.1.18), thus preventing the virus from budding from the host cell.
antiviral agent  A substance that destroys or inhibits replication of viruses.
Application:
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor  An antiviral drug targeted at influenza viruses. Its mode of action consists of blocking the function of the viral neuraminidase protein (EC 3.2.1.18), thus preventing the virus from budding from the host cell.
ChEBI Ontology
Outgoing Relation(s)
zanamivir (CHEBI:50663) has role antiviral agent (CHEBI:22587)
zanamivir (CHEBI:50663) has role EC 3.2.1.18 (exo-α-sialidase) inhibitor (CHEBI:52425)
zanamivir (CHEBI:50663) is a guanidines (CHEBI:24436)
IUPAC Name 
5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
INN  Source
zanamivirKEGG DRUG
Synonyms  Source
(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acidIUPAC
4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acidChemIDplus
4-guanidino-Neu5Ac2enChemIDplus
5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acidChemIDplus
5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acidIUPAC
GANAChemIDplus
Brand Name  Source
RelenzaKEGG DRUG
Manual XrefsDatabases
2859DrugCentral
C08095KEGG COMPOUND
D00902KEGG DRUG
DB00558DrugBank
US5360817Patent
WO9116320Patent
ZanamivirWikipedia
ZMRPDBeChem
Registry NumbersSources
Beilstein:7083099Beilstein
CAS:139110-80-8KEGG COMPOUND
CAS:139110-80-8ChemIDplus